August 25, 2023 Comments Off on New patent for Gilead Sciences drug EPCLUSA Posted in: Patent Added Annual Drug Patent Expirations for EPCLUSA Epclusa is a drug marketed by Gilead Sciences Inc and is included in two NDAs. It is available from two suppliers. There are fifteen…
The post New patent for Gilead Sciences drug EPCLUSA appeared first on Drug…
August 25, 2023 Comments Off on New patent expiration for Abbvie drug LATISSE Posted in: Uncategorized
Annual Drug Patent Expirations for LATISSE Latisse is a drug marketed by Abbvie and is included in one NDA. It is available from one supplier. There are eight patents protecting…
The post New patent expiration for Abbvie drug LATISSE appeared first on …
